Foundation Fighting Blindness
Foundation Fighting Blindness
Add to My Podcasts
Episodes
About
Reviews
Promote
Atsena Therapeutics Advances to Pivotal Phase 3 Trial for X-Linked Retinoschisis
3 minutes
Posted Apr 21, 2026 at 2:37 pm.
0:00
3:21
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
Data monitoring committee recommends proceeding with registration-enabling study for ATSN-201
Previous
MeiraGTx Announces the Acquisition of Botaretigene Sparoparvovec (bota-vec) for the Treatment of X-linked Retinitis Pigmentosa (XLRP)
Next
Foundation Fighting Blindness Celebrates Bennett, Maguire, and High's Breakthrough Prize for Revolutionary Gene Therapy
← See all 261 episodes of Foundation Fighting Blindness
